WA
HQL

WPG Advisers’s abrdn Life Sciences Investors HQL Stock Holding History

WPG Advisers’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.9K Sell
944
-1
-0.1% -$18 0.01% 567
2026
Q1 		$15.4K Buy
945
+152
+19% +$2.54K 0.01% 553
2025
Q4 		$13.3K Buy
793
+215
+37% +$3.61K 0.01% 617
2025
Q3 		$8.96K Buy
578
+110
+24% +$1.51K 0.01% 727
2025
Q2 		$6K Buy
468
+299
+177% +$3.69K 0.01% 820
2025
Q1 		$2.15K Buy
+169
New +$2.29K ﹤0.01% 1101

Other funds holding HQL

LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
BBPWM
Blue Bell Private Wealth Management Blue Bell, Pennsylvania $802M AUM 22.13% 1-Year Est. Return
UPS
UHLMANN PRICE SECURITIES Skokie, Illinois $2.68B AUM 149.5% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
SI
Stephens Inc Little Rock, Arkansas $8.93B AUM 25.13% 1-Year Est. Return

WPG Advisers's HQL Position: Q2 2026 in Review

WPG Advisers reduced its abrdn Life Sciences Investors (HQL) stake by 0.11% in Q2 2026, selling an estimated $18 and leaving 944 shares worth $18.9K. The position accounts for 0.01% of the portfolio, ranked #567.

WPG Advisers first reported a position in HQL in Q1 2025 and has held it in 6 quarters since. 45 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • WPG Advisers held 944 shares of abrdn Life Sciences Investors worth $18.9K as of Q2 2026.
  • WPG Advisers sold 1 abrdn Life Sciences Investors share in Q2 2026, an estimated $18.
  • abrdn Life Sciences Investors made up 0.01% of WPG Advisers's portfolio in Q2 2026, its #567 holding.
  • WPG Advisers first reported a position in abrdn Life Sciences Investors in Q1 2025 and has held it in 6 quarters since.
  • 45 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.